Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate

BACKGROUND: Concern for the development of extrapyramidal side effects (EPSEs) represents a barrier to the routine use of long-acting injectable (LAI) antipsychotic medication in patients with first-episode schizophrenia (FES). Flupenthixol decanoate is a first-generation antipsychotic, which is rea...

Descripción completa

Detalles Bibliográficos
Autores principales: Joubert, Francois-Pierre, Chiliza, Bonginkosi, Emsley, Robin, Asmal, Laila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876946/
https://www.ncbi.nlm.nih.gov/pubmed/33604077
http://dx.doi.org/10.4102/sajpsychiatry.v27i0.1568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876946/
https://www.ncbi.nlm.nih.gov/pubmed/33604077
http://dx.doi.org/10.4102/sajpsychiatry.v27i0.1568

Ejemplares similares